1 completed, 1 recruiting, 1 withdrawn. 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Withdrawn 1 |
Follow Recent Myocardial Infarction: new trials by email Literature Review of Recent Myocardial Infarction trials Research Report on Recent Myocardial Infarction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants CG-0255 Besylate for Injection, CG-0255 Besylate Capsule, Clopidogrel - Acute Coronary Syndromes (ACS), Recent Myocardial Infarction | Phase 1 | Recruiting | Shanghai CureGene Pharmaceutical Co., Ltd. | 136 | 2026-06-01 | 2026-06-29 |
| Effects of Interval Physical Training on Expiratory Flow Limitation in Recent Myocardial Infarction Interval Training (IT), Inspiratory Muscle Training (IMT) - Expiratory Flow Limitation, Recent Myocardial Infarction | Not applicable | Withdrawn | Federal University of Uberlandia | 2019-07-04 | 2020-05-05 | |
| CArdiosphere-Derived aUtologous Stem CElls to Reverse ventricUlar dySfunction Autologous stem cell infusion - Recent Myocardial Infarction, Ventricular Dysfunction | Phase 1 | Completed | Cedars-Sinai Medical Center | 31 | 2009-05-01 | 2014-02-12 |
Acute Coronary Syndrome (1) · Myocardial Infarction (1) · Peripheral Arterial Disease (1) · Ventricular Dysfunction (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Myocardial Ischemia (2) · Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Infarction (1) · Ischemia (1) · Necrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Peripheral Vascular Diseases (1)
Clopidogrel (1) · High-Intensity Interval Training (1) · Injections (1)
Cedars-Sinai Medical Center (1) · Federal University of Uberlandia (1) · Shanghai CureGene Pharmaceutical Co., Ltd. (1)
United States (2) · Brazil (1)
Debora LZ Scheucher, M.S. (1) · Eduardo Marban, MD, PhD (1)
PMID 21330601, PMID 21454794, PMID 22336189, PMID 24036024
U54HL081028 (1)